There have been huge changes in the way highly regulated markets operate in recent years – caused by new regulations.technologies and demands.Manufacturers and 6 April 2023
Improving the availability of innovative medicines in Latin America is a key priority for the pharmaceutical industry, policymakers, and patients. 31 March 2023
The progress quietly made by Sino-American biotech company Beigene (Nasdaq: BGNE) with its oral Bruton tyrosine kinase inhibitor (BTKi) Brukinsa (zanubrutinib) 30 March 2023
It seems every other day we hear of a new cyberattack in the news and it’s clear that these attacks are becoming an ever-growing, global concern. 27 March 2023
Research-based Egyptian pharma company Gennecs Pharmaceuticals, part of the Gennecs group, belongs to the to El Daba Holding Group, a trading conglomerate servi 20 March 2023